We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

125 hedge funds and large institutions have $197M invested in Provention Bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 32 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 32

28% more call options, than puts

Call options by funds: $8.58M | Put options by funds: $6.67M

26% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 19

4% more funds holding

Funds holding: 120 → 125 (+5)

21% less capital invested

Capital invested by funds: $248M → $197M (-$51.3M)

Holders
125
Holders Change
+5
Holders Change %
+4.17%
% of All Funds
2.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
48
Reduced
32
Closed
19
Calls
$8.58M
Puts
$6.67M
Net Calls
+$1.9M
Net Calls Change
-$4.34M

Top Buyers

Rank Fund Capital Flow
1
VA
VR Adviser
New York
+$23.4M
2
SC
Sessa Capital
New York
+$22.5M
3
State Street
State Street
Massachusetts
+$1.96M
4
Millennium Management
Millennium Management
New York
+$1.84M
5
PPA
Parametric Portfolio Associates
Washington
+$1.79M

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$22.8M
2
PA
Perceptive Advisors
New York
-$15.4M
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$7.16M
4
Two Sigma Investments
Two Sigma Investments
New York
-$4.04M
5
6CM
683 Capital Management
New York
-$2.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Board of Administration of Florida Retirement System
76
State Board of Administration of Florida Retirement System
Florida
$128K +$4.97K +616 +4%
Principal Financial Group
77
Principal Financial Group
Iowa
$123K -$74.2K -9,192 -39%
BAAM
78
Baker Avenue Asset Management
California
$120K – – –
MLICM
79
Metropolitan Life Insurance Company (MetLife)
New York
$116K +$12.3K +1,525 +12%
Cetera Investment Advisers
80
Cetera Investment Advisers
Illinois
$116K +$29.1K +3,605 +35%
Verition Fund Management
81
Verition Fund Management
Connecticut
$116K +$111K +13,718 New
EGM
82
Engineers Gate Manager
New York
$114K +$1.73K +214 +2%
ASRS
83
Arizona State Retirement System
Arizona
$113K -$2.67K -331 -2%
HSBC Holdings
84
HSBC Holdings
United Kingdom
$110K +$20K +2,475 +24%
NFSG
85
Newbridge Financial Services Group
Florida
$110K +$52.4K +6,500 +100%
Two Sigma Advisers
86
Two Sigma Advisers
New York
$109K -$7.16M -887,500 -99%
Rafferty Asset Management
87
Rafferty Asset Management
New York
$108K +$103K +12,815 New
BC
88
Bridgefront Capital
Texas
$107K +$103K +12,725 New
PCM
89
Prelude Capital Management
New York
$95K +$91.2K +11,300 New
WS
90
Wedbush Securities
California
$93K – – –
T. Rowe Price Associates
91
T. Rowe Price Associates
Maryland
$85K +$81.2K +10,063 New
I
92
INVST
Indiana
$72K +$95.2K +11,800 New
Zurich Cantonal Bank
93
Zurich Cantonal Bank
Switzerland
$70K +$2.75K +341 +4%
MIM
94
MetLife Investment Management
New Jersey
$68.3K -$109K -13,497 -62%
Barclays
95
Barclays
United Kingdom
$59K +$54K +6,698 +2,106%
BNP Paribas Financial Markets
96
BNP Paribas Financial Markets
France
$57.4K -$282 -35 -0.5%
Royal Bank of Canada
97
Royal Bank of Canada
Ontario, Canada
$55K +$16.3K +2,026 +45%
US Bancorp
98
US Bancorp
Minnesota
$53K +$10K +1,239 +25%
Legal & General Group
99
Legal & General Group
United Kingdom
$49K -$11.4K -1,418 -20%
DAC
100
Dividend Assets Capital
South Carolina
$42K – – –
2 3
4
5 6

PRVB Hedge Fund Activity: Q2 2021 in Review

125 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q2 2021, worth a combined $197M — down 21% from $248M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PRVB positions and 19 closed out — a net gain of 5 holders — while 48 added to existing stakes and 32 trimmed.

The largest buyer was VR Adviser, opening a new position worth an estimated $23.4M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $22.8M.

  • 125 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q2 2021, up from 120 in Q1 2021.
  • Funds reported $197M of Provention Bio, Inc. Common Stock stock for Q2 2021, down 21% quarter-over-quarter.
  • 24 funds opened new Provention Bio, Inc. Common Stock positions in Q2 2021 and 19 closed out, a net change of +5 holders.
  • The largest Provention Bio, Inc. Common Stock buyer in Q2 2021 was VR Adviser, an estimated $23.4M added.
  • The largest Provention Bio, Inc. Common Stock seller in Q2 2021 was Gilder Gagnon Howe & Co, an estimated $22.8M sold.

Based on aggregated 13F filings for Q2 2021.